Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis. (Q49895116)
Jump to navigation
Jump to search
scientific article published in January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis. |
scientific article published in January 2018 |
Statements
Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis (English)
Fei Qin
Hao Yu
Chang-Rong Xu
Hui-Hui Chen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference